← SageRanks

Fisher on the OMXC25

This ranking weighs Revenue growth ×4, Analyst upside ×3, Buy % ×2, Gross margin ×2, and nothing else, across the 23 companies we track on the OMXC25. Fisher set no numeric limits at all, so no company here is ever flagged: his fifteen points are qualitative.

Ranked highest by Fisher on this market right now, which is not the same list as the one that clears the limits above:

  1. Bavarian Nordic (BAVA.CO) · Healthcare · Revenue growth 23.2% · Analyst upside 35.7% · Buy % 100% · Gross margin 50%
  2. Genmab (GMAB.CO) · Healthcare · Revenue growth 24.9% · Analyst upside 17.8% · Buy % 76% · Gross margin 93%
  3. DSV (DSV.CO) · Industrials · Revenue growth 23.7% · Analyst upside 50.8% · Buy % 95% · Gross margin 27%
  4. Netcompany (NETC.CO) · Technology · Revenue growth 43.3% · Analyst upside 21.1% · Buy % 63% · Gross margin 27%
  5. Ørsted (ORSTED.CO) · Utilities · Revenue growth 20.5% · Analyst upside 27.1% · Buy % 44% · Gross margin 45%

From data as of 2026-09-11 01:00:55 UTC. Rebuilt every hour; the table above is live.

All 23 companies on the OMXC25, ranked by Fisher, as text
  1. Bavarian Nordic (BAVA.CO) · Revenue growth 23.2% · Analyst upside 35.7% · Buy % 100% · Gross margin 50%
  2. Genmab (GMAB.CO) · Revenue growth 24.9% · Analyst upside 17.8% · Buy % 76% · Gross margin 93%
  3. DSV (DSV.CO) · Revenue growth 23.7% · Analyst upside 50.8% · Buy % 95% · Gross margin 27%
  4. Netcompany (NETC.CO) · Revenue growth 43.3% · Analyst upside 21.1% · Buy % 63% · Gross margin 27%
  5. Ørsted (ORSTED.CO) · Revenue growth 20.5% · Analyst upside 27.1% · Buy % 44% · Gross margin 45%
  6. Rockwool (ROCK-B.CO) · Revenue growth 9.6% · Analyst upside 23.3% · Buy % 63% · Gross margin 67%
  7. Ambu (AMBU-B.CO) · Revenue growth 8.8% · Analyst upside 28.8% · Buy % 50% · Gross margin 60%
  8. FLSmidth (FLS.CO) · Revenue growth 16.8% · Analyst upside 9.5% · Buy % 92% · Gross margin 35%
  9. ISS (ISS.CO) · Revenue growth 7.4% · Analyst upside 12.3% · Buy % 67% · Gross margin 92%
  10. Demant (DEMANT.CO) · Revenue growth 14.8% · Analyst upside 3.1% · Buy % 68% · Gross margin 76%
  11. Carlsberg (CARL-B.CO) · Revenue growth 2.6% · Analyst upside 22.7% · Buy % 78% · Gross margin 45%
  12. Vestas (VWS.CO) · Revenue growth 26.1% · Analyst upside 2.0% · Buy % 52% · Gross margin 15%
  13. Ringkjøbing LB (RILBA.CO) · Revenue growth 5.9% · Analyst upside 5.5% · Buy % 75%
  14. GN Store Nord (GN.CO) · Revenue growth -5.7% · Analyst upside 19.4% · Buy % 58% · Gross margin 55%
  15. Coloplast B A/S (COLO-B.CO) · Revenue growth 5.7% · Analyst upside 9.4% · Buy % 14% · Gross margin 67%
  16. Tryg (TRYG.CO) · Revenue growth 5.3% · Analyst upside 9.9% · Buy % 47% · Gross margin 30%
  17. Novo Nordisk (NOVO-B.CO) · Revenue growth 2.1% · Analyst upside 8.0% · Buy % 27% · Gross margin 82%
  18. Royal Unibrew (RBREW.CO) · Revenue growth -0.3% · Analyst upside 17.5% · Buy % 40% · Gross margin 43%
  19. NNIT (NNIT.CO) · Revenue growth -6.7% · Analyst upside 31.6% · Buy % 33% · Gross margin 24%
  20. DFDS (DFDS.CO) · Revenue growth 9.9% · Analyst upside 3.0% · Buy % 33% · Gross margin 17%
  21. Pandora (PNDORA.CO) · Revenue growth 2.0% · Analyst upside 5.5% · Buy % 26% · Gross margin 79%
  22. A.P. Møller (MAERSK-B.CO) · Revenue growth 20.0% · Analyst upside -24.8% · Buy % 5% · Gross margin 21%
  23. Jyske Bank (JYSK.CO) · Revenue growth 1.3% · Analyst upside -0.7% · Buy % 33%